Takenari Yamashita

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Testing of the therapeutic efficacy and safety of AMPA receptor RNA aptamers in an ALS mouse model.

Testing of the therapeutic efficacy and safety of AMPA receptor RNA aptamers in an ALS mouse model.

Journal: Life science alliance

Published: August 14, 2021

Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases.

Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases.

Journal: International journal of molecular sciences

Published: May 16, 2019

Impaired Nucleoporins Are Present in Sporadic Amyotrophic Lateral Sclerosis Motor Neurons that Exhibit Mislocalization of the 43-kDa TAR DNA-Binding Protein.

Impaired Nucleoporins Are Present in Sporadic Amyotrophic Lateral Sclerosis Motor Neurons that Exhibit Mislocalization of the 43-kDa TAR DNA-Binding Protein.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: June 18, 2018

ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.

ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.

Journal: Neuroscience research

Published: May 10, 2018

Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.

Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.

Journal: Neuroscience research

Published: April 08, 2018

Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders.

Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders.

Journal: Translational psychiatry

Published: March 09, 2017

Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis.

Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis.

Journal: Genes

Published: November 17, 2016

A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility.

A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility.

Journal: Translational psychiatry

Published: November 03, 2016

Abnormal RNA editing and treatment strategy in neurological diseases; towards cure for ALS

Abnormal RNA editing and treatment strategy in neurological diseases; towards cure for ALS

Journal: Seikagaku. The Journal of Japanese Biochemical Society

Published: October 01, 2016

Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons.

Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons.

Journal: Scientific reports

Published: September 05, 2016

The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice.

The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice.

Journal: Scientific reports

Published: February 17, 2016

Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.

Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: October 09, 2015

Showing 1-12 of 23

Last Updated: 09/26/2026